Literature DB >> 12899683

Androgen 5-alpha-reductase type 2 is highly expressed and active in rat spinal cord motor neurones.

P Pozzi1, C Bendotti, S Simeoni, F Piccioni, V Guerini, T U Marron, L Martini, A Poletti.   

Abstract

Spinal cord motoneurones express high levels of androgen receptor. However, in responsive tissue, the effects of testosterone is often mediated by the more potent androgenic derivative 5-alpha-dihydrotestosterone (DHT). This compound is formed in androgen target cells by the enzyme 5-alpha-reductase. Two isoforms of the 5-alpha-reductase, with limited degree of homology, have been cloned, type 1 and type 2. The low affinity-constitutive type 1 isoenzyme is widely distributed in the body; the high affinity-androgen regulated 5-alpha-reductase type 2 is confined to androgen-dependent structures and shows a peculiar pH optimum at acidic values. We have previously shown that high levels of 5-alpha-reductase activity are detectable in rat spinal cord. Here, using reverse transcriptase-polymerase chain reaction, we show that both isoforms are expressed in the whole spinal cord of the rat. The enzymatic pH optimum measured in immortalized spinal cord motoneurones (NSC34) is typical of the type 2 isoenzyme. Using in situ hybridization technique, we found that 5-alpha-reductase type 2 is confined to the motoneuronal cells of the anterior horns of the rat spinal cord, the cells that also are known to express high levels of androgen receptor. Because of the close association of androgen receptor and 5-alpha alpha-reductase type 2, motoneuronal cells should be considered as target cells for androgens.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12899683     DOI: 10.1046/j.1365-2826.2003.01074.x

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


  22 in total

Review 1.  Developing treatment for spinal and bulbar muscular atrophy.

Authors:  Kenneth H Fischbeck
Journal:  Prog Neurobiol       Date:  2012-06-02       Impact factor: 11.685

Review 2.  Neurogenic pain and steroid synthesis in the spinal cord.

Authors:  Christine Patte-Mensah; Cherkaouia Kibaly; Domitille Boudard; Véronique Schaeffer; Aurélie Béglé; Simona Saredi; Laurence Meyer; Ayikoe G Mensah-Nyagan
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

Review 3.  Androgen regulation of axon growth and neurite extension in motoneurons.

Authors:  Keith N Fargo; Mariarita Galbiati; Eileen M Foecking; Angelo Poletti; Kathryn J Jones
Journal:  Horm Behav       Date:  2008-02-15       Impact factor: 3.587

4.  Testosterone metabolites differentially maintain adult morphology in a sexually dimorphic neuromuscular system.

Authors:  Tom Verhovshek; Katherine E Buckley; Melissa A Sergent; Dale R Sengelaub
Journal:  Dev Neurobiol       Date:  2010-03       Impact factor: 3.964

Review 5.  Animal models of Kennedy disease.

Authors:  Diane E Merry
Journal:  NeuroRx       Date:  2005-07

Review 6.  Progress in Spinobulbar muscular atrophy research: insights into neuronal dysfunction caused by the polyglutamine-expanded androgen receptor.

Authors:  L K Beitel; T Scanlon; B Gottlieb; M A Trifiro
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

7.  5α-reductase 1 regulates spinal cord testosterone after morphine administration.

Authors:  Alireza Sharif; Alireza Shoae-Hassani; Shiva Sharif; Hamid Reza Banafshe; Seyed Abdolreza Mortazavi-Tabatabaei; Javad Verdi
Journal:  Neurol Sci       Date:  2012-01-19       Impact factor: 3.307

Review 8.  The Role of Sex and Sex Hormones in Neurodegenerative Diseases.

Authors:  Elisabetta Vegeto; Alessandro Villa; Sara Della Torre; Valeria Crippa; Paola Rusmini; Riccardo Cristofani; Mariarita Galbiati; Adriana Maggi; Angelo Poletti
Journal:  Endocr Rev       Date:  2020-04-01       Impact factor: 19.871

9.  Androgenic, but not estrogenic, protection of motoneurons from somal and dendritic atrophy induced by the death of neighboring motoneurons.

Authors:  Keith N Fargo; Dale R Sengelaub
Journal:  Dev Neurobiol       Date:  2007-07       Impact factor: 3.964

10.  A multiscale, mechanism-driven, dynamic model for the effects of 5α-reductase inhibition on prostate maintenance.

Authors:  Michael G Zager; Hugh A Barton
Journal:  PLoS One       Date:  2012-09-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.